This new, interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation...
High Price :0.00 | Low Price : 0.00
(Webinar Held: November 6) Overloaded inboxes, overflowing to-do lists, endless meetings and only one you. How could you possibly get everything done? You work late hours, bring work home and still the...
This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.
PRICE : 0.00 - 0.00
The 90th Edition HDA Factbook (2019–2020) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
PRICE : $0.00 - $0.00
The 11th edition of the HDA Research Foundation’s annual benchmarking publication on specialty pharmaceuticals offers insight into this unique marketplace, and closely examines specialty distribution measures...
The fourth edition of this survey provides unbiased, objective data on the current readiness of manufacturers and distributors to meet DSCSA’s requirements.
Since 1992, the 340B Drug Pricing Program has played a modest, but increasingly important, role in the U.S. healthcare market.
Product returns are inevitable. Annually, more than 120 million product units — exceeding $13 billion in value — move through the reverse distribution process.
This whitepaper provides an analysis of the current market for biosimilars in the U.S. through interviews conducted with senior executives from specialty pharmaceutical manufacturing and distribution companies.
Through interviews, survey work and secondary data, this publication provides an understanding of the role distributors play to ensure the efficient and effective distribution of specialty medications.